Levodopa-induced Dyskinesia
📧 Sign up to get email alerts when something new happens for Levodopa-induced Dyskinesia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-07-10FDA Approved: GOCOVRI — Supplemental Application (Adamas Pharma, LLC)
The FDA approved a supplemental application for GOCOVRI (amantadine) submitted by Adamas Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients with Levodopa Induced Dyskinesia [Phase 2]
This Phase 2 trial evaluated the efficacy, safety, and pharmacokinetics of CPL500036 in patients with levodopa-induced dyskinesia in Parkins…
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Open-Label Safety Study of ADS-5102 in PD Patients With LID [Phase 3]
Open-label safety study of ADS-5102 in Parkinson's disease patients with levodopa-induced dyskinesia completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-04-02Clinical Trial Update: Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID [Phase 3]
Phase 3 trial evaluating amantadine hydrogen chloride ER tablets in Parkinson's disease patients with Levodopa-induced dyskinesia was termin…
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Unilateral Pallidotomy in the Treatment of Dyskinesia of Parkinson's Disease [Phase 1]
Phase 1 feasibility study assessing safety and initial effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound as a unilateral p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia [Phase 1, Phase 2]
A Phase 1/2 safety, tolerability, PK and PD study of Neu-120 for Levodopa-induced Dyskinesia was terminated.
-
CLINICAL_TRIALS trial_result · 2018-02-06Clinical Trial Update: ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study) [Phase 3]
Phase 3 trial update for ADS-5102 (amantadine) in levodopa-induced dyskinesia shows completed study with posted results in 2018.
-
CLINICAL_TRIALS trial_result · 2018-01-10Clinical Trial Update: Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia [Phase 3]
Phase 3 trial evaluating ADS-5102 for dyskinesia in Parkinson's disease patients treated with levodopa has completed and results were posted…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study) [Phase 2, Phase 3]
Clinical trial update reporting safety and efficacy findings for extended-release amantadine in levodopa-induced dyskinesia in Parkinson's d…
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia [Phase 2]
This Phase 2 trial update reports efficacy and safety results for JM-010 in Parkinson's disease patients with levodopa-induced dyskinesia.